Financials Inotiv, Inc.

Equities

NOTV

US45783Q1004

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
4.05 USD -5.59% Intraday chart for Inotiv, Inc. -6.25% +10.35%

Valuation

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 52.53 465.8 431.3 79.41 104.5 - -
Enterprise Value (EV) 1 52.53 465.8 431.3 79.41 104.5 104.5 104.5
P/E ratio -11.1 x 154 x -1.22 x -0.75 x -3.52 x -3.82 x -
Yield - - - - - - -
Capitalization / Revenue 0.87 x 5.2 x 0.79 x 0.14 x 0.18 x 0.17 x 0.17 x
EV / Revenue 0.87 x 5.2 x 0.79 x 0.14 x 0.18 x 0.17 x 0.17 x
EV / EBITDA - 50 x 4.77 x 1.21 x 1.36 x 1.25 x -
EV / FCF - -270 x -10.4 x 209 x 2.83 x 2.24 x 1.82 x
FCF Yield - -0.37% -9.63% 0.48% 35.4% 44.7% 54.8%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 10,989 15,929 25,594 25,783 25,791 - -
Reference price 2 4.780 29.24 16.85 3.080 4.050 4.050 4.050
Announcement Date 12/21/20 12/16/21 1/10/23 12/11/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Net sales 1 60.47 89.6 547.7 572.4 580.9 601.9 625.5
EBITDA 1 - 9.318 90.5 65.82 76.7 83.78 -
EBIT 1 - -5.618 -263.5 -81.46 6.522 13.82 21.89
Operating Margin - -6.27% -48.11% -14.23% 1.12% 2.3% 3.5%
Earnings before Tax (EBT) 1 - 6.119 -352.4 -124.2 -35.43 -30.37 -
Net income 1 - 10.9 -337 -105.1 -29.78 -27.84 -
Net margin - 12.16% -61.54% -18.37% -5.13% -4.63% -
EPS 2 -0.4300 0.1900 -13.84 -4.100 -1.150 -1.060 -
Free Cash Flow 1 - -1.726 -41.52 0.38 36.94 46.64 57.29
FCF margin - -1.93% -7.58% 0.07% 6.36% 7.75% 9.16%
FCF Conversion (EBITDA) - - - 0.58% 48.16% 55.68% -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 12/21/20 12/16/21 1/10/23 12/11/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 30.08 84.21 140.3 172.7 150.5 122.8 151.5 157.5 140.7 135.5 135.7 151.3 158.4 141.8 142.8
EBITDA 1 4.335 10.12 25.26 36.98 18.26 -5.481 17.1 30.52 23.68 9.616 12.17 24.86 30.06 13.78 14.27
EBIT 1 -3.408 -33.64 7.868 4.787 -242.5 -90.58 -2.125 8.783 2.46 -9.371 -4.294 8.224 11.93 - -
Operating Margin -11.33% -39.95% 5.61% 2.77% -161.14% -73.79% -1.4% 5.58% 1.75% -6.92% -3.16% 5.43% 7.53% - -
Earnings before Tax (EBT) 1 9.312 -96.2 0.182 -3.214 -253.2 -102.9 -12.1 -2.015 -7.226 -19.32 -14.97 -2.402 1.252 - -
Net income 1 9.382 -83.05 -6.087 -3.728 -244.2 -87.32 -9.994 1.84 -9.663 -15.39 -13.94 -2.13 1.629 - -
Net margin 31.19% -98.62% -4.34% -2.16% -162.27% -71.14% -6.6% 1.17% -6.87% -11.36% -10.27% -1.41% 1.03% - -
EPS 2 0.0600 -3.930 -0.2400 -0.1500 -9.540 -3.410 -0.3900 0.0700 -0.3800 -0.6000 -0.5400 -0.0850 0.0650 - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 12/16/21 2/10/22 5/12/22 8/10/22 1/10/23 2/13/23 5/11/23 8/10/23 12/11/23 2/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -1.73 -41.5 0.38 36.9 46.6 57.3
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - 12.5 36 27.5 26.5 26.5 27.8
Capex / Sales - 13.92% 6.58% 4.8% 4.56% 4.4% 4.45%
Announcement Date 12/21/20 12/16/21 1/10/23 12/11/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.05 USD
Average target price
15.5 USD
Spread / Average Target
+282.72%
Consensus
  1. Stock Market
  2. Equities
  3. NOTV Stock
  4. Financials Inotiv, Inc.